Ledger.Open graph →
SEC Form D · filed April 21, 2015

Innocrin Pharmaceuticals Holdings, LLC

Offering
$28.1M
Sold
$28.1M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (23)

Thomas E. Laundon · Durham, NCExecS. E. Torres · Durham, NCDirectorSteven Weinstein · Durham, NCDirectorRobert E. Schotzinger · Durham, NCDirectorKristopher E. Wood · Durham, NCDirectorDouglas Reed · Durham, NCDirectorWilliam Moore · Durham, NCExec · DirectorAndrew E. Von Eschenbach · Durham, NCDirectorRichard Kent · Lutherville, MDDirectorFred E. Eshelman · Durham, NCDirectorMichael A. Smerklo · Minneapolis, MNDirectorRobin Rose · Boston, MADirectorCharles A. Wilkinson · New York, NYDirectorJames J. Frome · Minneapolis, MNDirectorJames B. Ramsey · Minneapolis, MNExec · DirectorMichael B. Gorman · Minneapolis, MNExec · DirectorArchie C. Black · Minneapolis, MNExec · DirectorKimberly K. Nelson · Minneapolis, MNDirectorMarcus Katz · Chicago, ILDirectorConstantinos J. Christofilis · Seattle, WADirectorArchon Capital Management LLC · Seattle, WADirectorStephen A. Mcshea · New York, NYDirectorDonald M. Wilkinson Iii · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗